Clinical trial

HDR Brachytherapy Plus Stereotactic Ablative Prostate Radiotherapy for Patients With Intermediate and High-risk Prostate Cancer

NCT04523896

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2019-07-01

PhasePHASE2

Study timeline

Study start (actual)2019-07-01Date precision: day

Registry last updated2020-08-24

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Prostatic Neoplasmunresolved

Interventions

Real time High-Dose-Rate prostate brachytherapy in combination with stereotactic prostate radiotherapyRADIATION

Sponsors & collaborators

David Büchserlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04523896 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.